DOI
10.1080/14737167.2020.1800455
Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China
作者地址
School of Economics, Lanzhou University, Lanzhou, Gansu, China
来源期刊
Expert Review of Pharmacoeconomics & Outcomes Research
摘要
Objectives The pharmacoeconomic studies of traditional Chinese medicine (TCM) are still in its infancy. Assessing the quality of pharmacoeconomic studies of TCM to improve the efficiency of health resource allocation and guide the rational use of medicine. Methods Four databases were searched from inception to January 2018. The Consolidated Health Economic Evaluation Reporting Standards statement (CHEERS) and the Quality of Health Economic Studies (QHES) were used to assess the reporting quality and methodological quality. STATA 12.0 and Meta analyst 3.13 were used to analyze the related data. Results A total of 178 studies were included. The methodological evaluation of the study found that the total score of QHES was 47.85 +/- 8.09. The report quality evaluation results found that many studies did not report comprehensive information, such as lack of detailed reports on abstracts, study perspectives, time frames, discount rates, model selection, but the titles, study background and location, and health results, resource and cost estimates, analysis methods, and heterogeneity analysis are reported in more detail. Six of the ten stratification factors have statistically significant differences. Conclusion The overall quality of pharmacoeconomic studies of TCM is low, and further standardization and improvement are needed to obtain reliable study results.
WOS学科分类
Health Care Sciences & Services
;
Health Policy & Services
;
Pharmacology & Pharmacy
WOS关键词
ECONOMIC EVALUATIONS
;
HEALTH
附件
-
401 Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China.pdf
761.32 kB
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
